These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1458730)

  • 21. Ultrasonography for the evaluation of visceral fat and cardiovascular risk.
    Ribeiro-Filho FF; Faria AN; Kohlmann O; Ajzen S; Ribeiro AB; Zanella MT; Ferreira SR
    Hypertension; 2001 Sep; 38(3 Pt 2):713-7. PubMed ID: 11566963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence.
    Imbeault P; Prins JB; Stolic M; Russell AW; O'Moore-Sullivan T; Després JP; Bouchard C; Tremblay A
    Diabetes Care; 2003 Feb; 26(2):480-4. PubMed ID: 12547885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.
    Matsuura F; Yamashita S; Nakamura T; Nishida M; Nozaki S; Funahashi T; Matsuzawa Y
    Metabolism; 1998 Aug; 47(8):929-33. PubMed ID: 9711987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology and pathogenesis of visceral fat obesity.
    Matsuzawa Y; Shimomura I; Nakamura T; Keno Y; Tokunaga K
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S111-6. PubMed ID: 7859591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The insulin receptor in myotonic dystrophy.
    Kobayashi M; Meek JC; Streib E
    J Clin Endocrinol Metab; 1977 Oct; 45(4):821-4. PubMed ID: 914985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men.
    Takahashi S; Yamamoto T; Tsutsumi Z; Moriwaki Y; Yamakita J; Higashino K
    Metabolism; 1997 Oct; 46(10):1162-5. PubMed ID: 9322800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men.
    Jang Y; Kim OY; Ryu HJ; Kim JY; Song SH; Ordovas JM; Lee JH
    J Lipid Res; 2003 Dec; 44(12):2356-64. PubMed ID: 12951360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The cutoff point of visceral fat area as a goal for improving risk factors of arteriosclerosis in patients with glucose intolerance].
    Nagano M; Sasaki H; Kumagai S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():417-20. PubMed ID: 15779415
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhanced intra-abdominal visceral fat accumulation in patients with Werner's syndrome.
    Mori S; Murano S; Yokote K; Takemoto M; Asaumi S; Take A; Saito Y
    Int J Obes Relat Metab Disord; 2001 Feb; 25(2):292-5. PubMed ID: 11410834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen.
    Suzuki R; Watanabe S; Hirai Y; Akiyama K; Nishide T; Matsushima Y; Murayama H; Ohshima H; Shinomiya M; Shirai K
    Am J Med; 1993 Sep; 95(3):309-14. PubMed ID: 8368228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate and lipid metabolism in relation to body composition in myotonic dystrophy.
    Björntorp P; Schröder G; Orndahl G
    Diabetes; 1973 Apr; 22(4):238-42. PubMed ID: 4696093
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucose transport and oxidation in adipose tissue of patients with myotonic dystrophy.
    Mably E; Strickland KP; Tevaarwerk GJ; Hudson AJ
    J Neurol Sci; 1981 Oct; 52(1):11-23. PubMed ID: 7028922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-abdominal fat, lipid metabolism and insulin resistance in coronary artery disease.
    Kawamoto T; Ishikawa K
    Hypertens Res; 1996 Jun; 19 Suppl 1():S69-74. PubMed ID: 9240769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of hyperglucagonemia in patients with myotonic dystrophy (author's transl)].
    Shimoda S; Suzuki H; Katayama S
    Nihon Naibunpi Gakkai Zasshi; 1981 Oct; 57(10):1521-30. PubMed ID: 7035234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Visceral fat obesity].
    Tarui S
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1547-53. PubMed ID: 8245658
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of rapid enhancement of insulin action after oral glucose challenge in myotonic dystrophy.
    Moxley RT; Kingston WJ; Griggs RC; Livingston JN
    Diabetes; 1987 Jun; 36(6):693-701. PubMed ID: 3552801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance in patients with myotonic dystrophy.
    Stuart CA; Armstrong RM; Provow SA; Plishker GA
    Neurology; 1983 Jun; 33(6):679-85. PubMed ID: 6341879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphasic response on oral glucose tolerance testing in myotonic dystrophy.
    Russell D; Sjaastad O
    Acta Neurol Scand; 1976 Mar; 53(3):226-8. PubMed ID: 1266569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy.
    Moxley RT; Livingston JN; Lockwood DH; Griggs RC; Hill RL
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2567-71. PubMed ID: 7017735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased binding of insulin to erythrocytes in myotonic dystrophy.
    Sakai K; Takase S; Kumagai K; Shimizu F
    Tohoku J Exp Med; 1985 Jun; 146(2):193-9. PubMed ID: 3895577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.